Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and Novo Nordisk have announced the establishment of an international postdoctoral fellowship programme to support research within the fields of diabetes, metabolism and endocrinology.

A total of 12 postdoctoral fellowships will be awarded, each for a 3 year period. The fellows will be hosted by Oxford University and funded by Novo Nordisk. The goal of the programme is to support the development of a new generation of research leaders while further developing scientific excellence within diabetes.

The programme will be coordinated through the Radcliffe Department of Medicine (RDM). The first four fellows in the programme will start in the autumn of 2014. Full details on the programme will be available shortly. Any queries should be directed to Dr Ruth McCaffrey.

The full text of the release is available.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Renewal of the Novo Nordisk – University of Oxford Fellowship Programme

Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.